Keith Lavan
2019
In 2019, Keith Lavan earned a total compensation of $413.3K as Chief Financial Officer at Petros Pharmaceuticals.
Compensation breakdown
| Salary | $335,297 |
|---|---|
| Other | $78,005 |
| Total | $413,302 |
Lavan received $335.3K in salary, accounting for 81% of the total pay in 2019.
Lavan also received $78K in other compensation.
Rankings
In 2019, Keith Lavan's compensation ranked 12,262nd out of 13,971 executives tracked by ExecPay. In other words, Lavan earned more than 12.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,262 out of 13,971 | 12th |
Division Manufacturing | 4,964 out of 5,695 | 13th |
Major group Chemicals And Allied Products | 1,952 out of 2,194 | 11th |
Industry group Drugs | 1,681 out of 1,880 | 11th |
Industry Pharmaceutical Preparations | 1,242 out of 1,392 | 11th |
Source: SEC filing on November 22, 2021.
Lavan's colleagues
We found three more compensation records of executives who worked with Keith Lavan at Petros Pharmaceuticals in 2019.